Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Creotech Instruments 3-Year EBITDA Growth Rate Related Terms
FRA:5OB vs SPCX, GE, RTX: 3-Year EBITDA Growth Rate Comparison
For the Aerospace & Defense subindustry, Creotech Instruments's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Creotech Instruments 3-Year EBITDA Growth Rate vs Aerospace & Defense Industry
For the Aerospace & Defense industry and Industrials sector, Creotech Instruments's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Creotech Instruments's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 0.00% mean?
Creotech Instruments (FRA:5OB) has a 3-Year EBITDA Growth Rate of 0.00% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Creotech Instruments and its competitors. According to the industry distribution chart, Creotech Instruments ranks #999999 out of 275 companies in the Aerospace & Defense industry.
Is Creotech Instruments' 3-Year EBITDA Growth Rate too high?
Creotech Instruments' current 3-Year EBITDA Growth Rate is 0.00%. Based on the distribution chart, Creotech Instruments ranks #999999 out of 275 companies in the Aerospace & Defense industry, which is in the bottom quartile relative to peers. Overall, Creotech Instruments has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Creotech Instruments' 3-Year EBITDA Growth Rate compare to SPCX and GE?
According to the Aerospace & Defense industry distribution chart, Creotech Instruments ranks #999999 out of 275 companies for 3-Year EBITDA Growth Rate. This places Creotech Instruments in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 13.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for an Aerospace & Defense company?
The median 3-Year EBITDA Growth Rate among Aerospace & Defense companies is 13.00, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Creotech Instruments and its competitors. For the Aerospace & Defense industry, the median 3-Year EBITDA Growth Rate is 13.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Creotech Instruments's current 3-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Creotech Instruments stock overvalued right now?
Based on GuruFocus' analysis, Creotech Instruments (FRA:5OB) is currently considered Possible Value Trap. The stock's GF Value™ is €231.92, compared to a current price of €159.00 — trading 31.4% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 0.00%. Creotech Instruments' overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Creotech Instruments (FRA:5OB), the current 3-Year EBITDA Growth Rate is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Creotech Instruments (FRA:5OB) Overvalued in 2026?
Based on GuruFocus' analysis, Creotech Instruments stock appears to be undervalued.
The current stock price of €159.00 is trading 31.4% below its estimated GF Value™ of €231.92.
GuruFocus considers Creotech Instruments to be Possible Value Trap.
Key valuation signals for FRA:5OB:
3-Year EBITDA Growth Rate: 0.00%
GF Value™: €231.92 vs. price of €159.00 (31.4% below fair value)
No single metric tells the full story. See the FRA:5OB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Creotech Instruments SA is a provider of advanced space technologies, specialized electronics, and hardware with global applications in areas such as quantum computers, quantum cryptography, quantum physics, and high energy physics laboratories. Its five primary business segments are: NewSpace dedicated to developing a satellite platform and its components; Earth Observation dedicated to developing Earth Observation systems and UAV technology (Unmanned Aerial Vehicle); Science dedicated to developing specialized electronics and components for quantum computers and time synchronization systems; Production dedicated to the manufacture of electronics; ESA Projects dedicated chiefly to projects carried in partnership with or/and commissioned by the European Space Agency (ESA).
78GF Score
Get the complete analysis for FRA:5OB
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5OB has been successfully added to your 
